Pain
Opinion
A new and completely different pain medicine
Patients assigned to the highest dose of VX-548 had a statistically significant lower cumulative amount of pain in the 48 hours after surgery.
Opinion
New DEA CME mandate affects 2 million prescribers
One should not underestimate the sweeping scope of this new federal requirement.
Conference Coverage
Migraine device expands treatment possibilities
New studies of remote electrical neuromodulation show efficacy in adolescents and safety during pregnancy.
News
Regular exercise may boost pain tolerance
“There were indications that both total amount of physical activity over time, as well as the direction of change in activity level over time...
Latest News
Positive top-line results for cannabinoid-based med for nerve pain
“Through this rigorously designed study, we have demonstrated that ZLT-L-007 is a safe, effective, and well-tolerated alternative for patients who...
News
Researchers locate signals in brain related to chronic pain
“Such patterns of brain activity could serve as biomarkers to guide diagnosis and treatment for millions of people with shooting or burning...
Latest News
FDA OKs spinal cord stimulation devices for chronic back pain
The indication for the devices now includes treatment of chronic back pain in patients who have not had, or are not eligible for, back surgery.
News
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
News
New guidelines for cannabis in chronic pain management released
New clinical practice guidelines for cannabis in chronic pain management may help clinicians offer an effective and less addictive alternative to...
News
Safety, efficacy of analgesics for low back pain ‘uncertain’
“When we set out to do this review, we envisioned the evidence would be a lot more comprehensive.”